# PEG-Interferon a-2b + Ribavirin for Treatment of Chronic HRN 005 Hepatitis C Infection in HIV-Infected Persons Not Previously Treated With Interferon

> **NCT00215891** · PHASE3 · COMPLETED · sponsor: **Hepatitis Resource Network** · enrollment: 300 (—)

## Conditions studied

- Chronic Hepatitis C Infection in HIV-Infected Persons
- HIV Infections

## Interventions

- **DRUG:** PEG-Interferon a-2b + Ribavirin

## Key facts

- **NCT ID:** NCT00215891
- **Lead sponsor:** Hepatitis Resource Network
- **Sponsor class:** OTHER
- **Phase:** PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** —
- **Primary completion:** —
- **Final completion:** —
- **Target enrollment:** 300 (—)
- **Last updated:** 2005-10-25

## Collaborators

- [object Object]
- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00215891

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00215891, "PEG-Interferon a-2b + Ribavirin for Treatment of Chronic HRN 005 Hepatitis C Infection in HIV-Infected Persons Not Previously Treated With Interferon". Retrieved via AI Analytics 2026-06-25 from https://api.ai-analytics.org/clinical/NCT00215891. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*